10X GENOMICS INC-CLASS A (TXG)

US88025U1097 - Common Stock

26.39  -0.17 (-0.64%)

After market: 26.39 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
490.5M
64.16%		516.4M
5.28%		618.727M
19.82%		685.67M
10.82%
EBITDA
YoY % growth
-31.18M
93.98%		-142.53M
-357.12%		-220.417M
-54.65%		-146.015M
33.75%		N/AN/AN/AN/A
EBIT
YoY % growth
-52.3M
90.16%		-167.9M
-221.03%		-255.929M
-52.43%		-199.529M
22.04%
Operating Margin
-10.66%-32.51%-41.36%-29.10%
EPS
YoY % growth
-0.52
89.86%		-1.47
-182.69%		-2.17
-47.62%		-1.63
25.05%		N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.49
8.02%
Revenue
Q2Q % growth		158.55M
8.00%
EBITDA
Q2Q % growth		-41.183M
EBIT
Q2Q % growth		-58.722M
3.10%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 -0.50
-13.64%		-0.510.011.07%
Q4 2023
Q2Q % growth		 -0.41
-173.33%		-0.36-0.05-13.26%
Q3 2023
Q2Q % growth		 -0.79
-113.51%		-0.46-0.33-70.21%
Q2 2023
Q2Q % growth		 -0.53
7.02%		-0.41-0.12-30.01%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 141.006M
4.99%		143.67M-2.664M-1.85%
Q4 2023
Q2Q % growth		 183.979M
17.78%		184.63M-651K-0.35%
Q3 2023
Q2Q % growth		 153.6M
17.16%		152.78M820K0.54%
Q2 2023
Q2Q % growth		 146.8M
28.10%		141.36M5.44M3.85%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.01% -12.17% 0% -8.3%
Revenue-0.17% -8.24% 0% -4.66%